Ligand validation:3VU2

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VU2_GOL_B_806	51%	93%	0.132	0.886	0.35	0.15	-	-	2	0	100%	1
3VU2_GOL_B_804	45%	83%	0.159	0.888	0.39	0.4	-	-	3	0	100%	1
3VU2_GOL_A_804	19%	90%	0.156	0.752	0.37	0.24	-	-	0	0	100%	1
3VU2_GOL_B_805	6%	88%	0.224	0.665	0.36	0.32	-	-	0	0	100%	1
3VU2_GOL_B_807	2%	90%	0.234	0.539	0.37	0.24	-	-	0	0	100%	1
3AML_GOL_A_759	91%	68%	0.074	0.961	0.29	0.94	-	-	0	0	100%	1
3AMK_GOL_A_706	36%	86%	0.152	0.844	0.32	0.4	-	-	2	0	100%	1
2NT0_GOL_D_506	100%	73%	0.016	0.997	0.3	0.72	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
3V5K_GOL_D_276	100%	96%	0.022	0.995	0.21	0.17	-	-	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.